Literature DB >> 26610878

Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.

Morie A Gertz1, Merrill D Benson2, Peter J Dyck3, Martha Grogan4, Terresa Coelho5, Marcia Cruz6, John L Berk7, Violaine Plante-Bordeneuve8, Hartmut H J Schmidt9, Giampaolo Merlini10.   

Abstract

Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant inheritance) and a wild-type form (with predominant cardiac involvement). This article guides clinicians as to when the disease should be suspected, describes the appropriate diagnostic evaluation for those with known or suspected amyloidosis, and reviews the interventions currently available for affected patients.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  familial amyloid cardiomyopathy; familial amyloid polyneuropathy; genetics; liver transplantation

Mesh:

Year:  2015        PMID: 26610878     DOI: 10.1016/j.jacc.2015.09.075

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  91 in total

1.  Assessment of the effects of transthyretin peptide inhibitors in Drosophila models of neuropathic ATTR.

Authors:  Lorena Saelices; Malgorzata Pokrzywa; Katarzyna Pawelek; David S Eisenberg
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

2.  Crystal structures of amyloidogenic segments of human transthyretin.

Authors:  Lorena Saelices; Stuart A Sievers; Michael R Sawaya; David S Eisenberg
Journal:  Protein Sci       Date:  2018-06-13       Impact factor: 6.725

3.  Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis.

Authors:  Sarah Pradel; Stéphanie Brun; Gérard Victor; Pierre Pascal; Pauline Fournier; David Ribes; Yoan Lavie-Badie; Michel Galinier; Didier Carrié; Isabelle Berry; Olivier Lairez
Journal:  J Nucl Cardiol       Date:  2018-06-07       Impact factor: 5.952

4.  Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.

Authors:  Balaji Tamarappoo; Yuka Otaki; Osamu Manabe; Mark Hyun; Stephanie Cantu; Yoav Arnson; Heidi Gransar; Sean W Hayes; John D Friedman; Louise Thomson; Piotr Slomka; Damini Dey; Robert Vescio; Jignesh Patel; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2019-06-06       Impact factor: 5.952

Review 5.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

6.  Patisiran for advanced heart failure with hereditary transthyretin cardiac amyloidosis.

Authors:  Makiko Nakamura; Teruhiko Imamura; Koichiro Kinugawa
Journal:  J Cardiol Cases       Date:  2021-02-08

7.  Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

Authors:  Kristina Dahlem; Guido Michels; Carsten Kobe; Alexander C Bunck; Henrik Ten Freyhaus; Roman Pfister
Journal:  Clin Res Cardiol       Date:  2017-03-16       Impact factor: 5.460

8.  Integrating imaging modalities for diagnosing cardiac amyloidosis.

Authors:  M Ahluwalia; A Reyentovich; R Donnino; L M Phillips
Journal:  J Nucl Cardiol       Date:  2018-07-09       Impact factor: 5.952

9.  [What gnaws at the heart and gets on the nerves].

Authors:  Arnt V Kristen
Journal:  Internist (Berl)       Date:  2018-11       Impact factor: 0.743

10.  A Heart too Stiff to Beat: A Case of Familial Transthyretin Amyloidosis Cardiomyopathy.

Authors:  Yan Zhou; Sameen Khalid; Aamer Abbass; Laura Hughes; Marcos Hazday
Journal:  Cureus       Date:  2017-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.